Browse > Article
http://dx.doi.org/10.4142/jvs.21242

Efficacy of genotype-matched Newcastle disease virus vaccine formulated in carboxymethyl sago starch acid hydrogel in chickens vaccinated via different routes  

Mahamud, Siti Nor Azizah (Laboratory of Vaccines and Biomolecules, Institute of Bioscience, Universiti Putra Malaysia)
Bello, Muhammad Bashir (Department of Veterinary Microbiology, Faculty of Veterinary Medicine, Usmanu Danfodiyo University)
Ideris, Aini (Laboratory of Vaccines and Biomolecules, Institute of Bioscience, Universiti Putra Malaysia)
Omar, Abdul Rahman (Laboratory of Vaccines and Biomolecules, Institute of Bioscience, Universiti Putra Malaysia)
Publication Information
Journal of Veterinary Science / v.23, no.4, 2022 , pp. 25.1-25.14 More about this Journal
Abstract
Background: The commercially available Newcastle disease (ND) vaccines were developed based on Newcastle disease virus (NDV) isolates genetically divergent from field strains that can only prevent clinical disease, not shedding of virulent heterologous virus, highlighting the need to develop genotype-matched vaccines Objectives: This study examined the efficacy of the NDV genotype-matched vaccine, mIBS025 strain formulated in standard vaccine stabilizer, and in carboxymethyl sago starch-acid hydrogel (CMSS-AH) following vaccination via an eye drop (ED) and drinking water (DW). Methods: A challenge virus was prepared from a recent NDV isolated from ND vaccinated flock. Groups of specific-pathogen-free chickens were vaccinated with mIBS025 vaccine strain prepared in a standard vaccine stabilizer and CMSS-AH via ED and DW and then challenged with the UPM/NDV/IBS362/2016 strain. Results: Chickens vaccinated with CMSS-AH mIBS025 ED (group 2) developed the earliest and highest Hemagglutination Inhibition (HI) NDV antibody titer (8log2) followed by standard mIBS025 ED (group 3) (7log2) both conferred complete protection and drastically reduced virus shedding. By contrast, chickens vaccinated with standard mIBS025 DW (group 5) and CMSS-AH mIBS025 DW (group 4) developed low HI NDV antibody titers of 4log2 and 3log2, respectively, which correspondingly conferred only 50% and 60% protection and continuously shed the virulent virus via the oropharyngeal and cloacal routes until the end of the study at 14 dpc. Conclusions: The efficacy of mIBS025 vaccines prepared in a standard vaccine stabilizer or CMSS-AH was affected by the vaccination routes. The groups vaccinated via ED had better protective immunity than those vaccinated via DW.
Keywords
Genotype matched NDV vaccine; carboxymethyl sago starch-acid hydrogel; vaccination routes; genotype VII NDV;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 OIE Terrestrial Manual 2018: Principle of Veterinary Vaccine Production [Internet]. Paris: OIE; https://www.oie.int/fileadmin/Home/eng/Health_standards/tahm/1.01.08_VACCINE_PRODUCTION.pdf. Updated 2018. Accessed 2021 Aug 25.
2 Okwor EC, Eze DC, Uzuegbu OM. Comparative studies on the oral and intraocular routes of administration of Newcastle disease vaccine, La Sota in adult chickens. IOSR J Agric Vet Sci.2013;3(3):48-51.   DOI
3 Virus Taxonomy [Internet]. [publisher unknown]: ICTV; https://talk.ictvonline.org/taxonomy/. Updated 2021. Accessed 2021 Aug 25.
4 Tan SW, Ideris A, Omar AR, Yusoff K, Hair-Bejo M. Sequence and phylogenetic analysis of Newcastle disease virus genotypes isolated in Malaysia between 2004 and 2005. Arch Virol. 2010;155(1):63-70.   DOI
5 Manual of Diagnostic Tests and Vaccines for Terrestrial Animals: Newcastle Disease [Internet]. Paris: OIE; https://www.oie.int/fileadmin/Home/eng/Health_standards/tahm/3.03.14_NEWCASTLE_DIS.pdf. Updated 2021. Accessed 2021 Aug 25.
6 Doyle TM. A hitherto unrecorded disease of fowls due to a filter-passing virus. J Comp Pathol Ther. 1927;40:144-169.
7 Xiao S, Paldurai A, Nayak B, Samuel A, Bharoto EE, Prajitno TY, et al. Complete genome sequences of Newcastle disease virus strains circulating in chicken populations of Indonesia. J Virol. 2012;86(10):5969-5970.   DOI
8 Dortmans JC, Peeters BP, Koch G. Newcastle disease virus outbreaks: vaccine mismatch or inadequate application? Vet Microbiol. 2012;160(1-2):17-22.   DOI
9 Dimitrov KM, Abolnik C, Afonso CL, Albina E, Bahl J, Berg M, et al. Updated unified phylogenetic classification system and revised nomenclature for Newcastle disease virus. Infect Genet Evol. 2019;74:103917.   DOI
10 Berhanu A, Ideris A, Omar AR, Bejo MH. Molecular characterization of partial fusion gene and C-terminus extension length of haemagglutinin-neuraminidase gene of recently isolated Newcastle disease virus isolates in Malaysia. Virol J. 2010;7(1):183.   DOI
11 Jaganathan S, Ooi PT, Phang LY, Allaudin ZN, Yip LS, Choo PY, et al. Observation of risk factors, clinical manifestations and genetic characterization of recent Newcastle disease virus outbreak in West Malaysia. BMC Vet Res. 2015;11:219.   DOI
12 Ansori ANM, Kharisma VD. Characterization of Newcastle disease virus in Southeast Asia and East Asia: fusion protein gene. J Sci Data Anal. 2020;1(1):14-20.
13 Aljumaili OA, Yeap SK, Omar AR, Aini I. Isolation and characterization of genotype VII Newcastle disease virus from NDV vaccinated farms in Malaysia. Pertanika J Trop Agric Sci. 2017;40(4):677-690.
14 Doan PT, Cahyono MI, Rabiei M, Pandarangga P, McAllister MM, Low WY, et al. Genome sequences of Newcastle disease virus strains from two outbreaks in Indonesia. Microbiol Resour Announc. 2020;9(23):e00205-20.
15 Tan SW, Ideris A, Omar AR, Yusoff K, Hair-Bejo M. Detection and differentiation of velogenic and lentogenic Newcastle disease viruses using SYBR Green I real-time PCR with nucleocapsid gene-specific primers. J Virol Methods. 2009;160(1-2):149-156.   DOI
16 Roohani K, Tan SW, Yeap SK, Ideris A, Bejo MH, Omar AR. Characterisation of genotype VII Newcastle disease virus (NDV) isolated from NDV vaccinated chickens, and the efficacy of LaSota and recombinant genotype VII vaccines against challenge with velogenic NDV. J Vet Sci. 2015;16(4):447-457.   DOI
17 Dimitrov KM, Afonso CL, Yu Q, Miller PJ. Newcastle disease vaccines-A solved problem or a continuous challenge? Vet Microbiol. 2017;206:126-136.   DOI
18 Sedeik ME, Elbestawy AR, El-Shall NA, Abd El-Hack ME, Saadeldin IM, Swelum AA. Comparative efficacy of commercial inactivated Newcastle disease virus vaccines against Newcastle disease virus genotype VII in broiler chickens. Poult Sci. 2019;98(5):2000-2007.   DOI
19 Bello MB, Mahamud SN, Yusoff K, Ideris A, Hair-Bejo M, Peeters BP, et al. Development of an effective and stable genotype-matched live attenuated Newcastle disease virus vaccine based on a novel naturally recombinant Malaysian isolate using reverse genetics. Vaccines (Basel). 2020;8(2):270.   DOI
20 Otiang E, Thumbi SM, Campbell ZA, Njagi LW, Nyaga PN, Palmer GH. Impact of routine Newcastle disease vaccination on chicken flock size in smallholder farms in western Kenya. PLoS One. 2021;16(3):e0248596.   DOI
21 Wegdan H, Mahasin E, Khallafalla AI. The effect of route of administration and dose on the immunogenicity and protective efficacy of Newcastle disease thermostable vaccine I2 strain. Int J Prev Med Res. 2015;1(5):276-281.
22 Satharasinghe DA, Murulitharan K, Tan SW, Yeap SK, Munir M, Ideris A, et al. Detection of inter-lineage natural recombination in avian paramyxovirus serotype 1 using simplified deep sequencing platform. Front Microbiol. 2016;7:1907.
23 Sultan HA, Talaat S, Elfeil WK, Selim K, Kutkat MA, Amer SA, et al. Protective efficacy of the Newcastle disease virus genotype VII-matched vaccine in commercial layers. Poult Sci. 2020;99(3):1275-1286.   DOI
24 Vaccine & Immunizations [Internet]. Atlanta: CDC; https://www.cdc.gov/vaccines/vac-gen/additives.htm. Updated 2019. Accessed 2021 Aug 25.
25 He T, Liang X, Li L, Gong S, Li X, Zhang M, et al. A spontaneously formed and self-adjuvanted hydrogel vaccine triggers strong immune responses. Mater Des. 2021;197:109232.   DOI
26 Diel DG, da Silva LH, Liu H, Wang Z, Miller PJ, Afonso CL. Genetic diversity of avian paramyxovirus type 1: proposal for a unified nomenclature and classification system of Newcastle disease virus genotypes. Infect Genet Evol. 2012;12(8):1770-1779.   DOI
27 Zhao K, Chen G, Shi XM, Gao TT, Li W, Zhao Y, et al. Preparation and efficacy of a live Newcastle disease virus vaccine encapsulated in chitosan nanoparticles. PLoS One. 2012;7(12):e53314.   DOI
28 Rasoli M, Yeap SK, Tan SW, Moeini H, Ideris A, Bejo MH, et al. Alteration in lymphocyte responses, cytokine and chemokine profiles in chickens infected with genotype VII and VIII velogenic Newcastle disease virus. Comp Immunol Microbiol Infect Dis. 2014;37(1):11-21.   DOI
29 Components of a Vaccine [Internet]. Geneva: WHO; https://vaccine-safety-training.org/vaccinecomponents.html#:~:text=Bacterial%20vaccines%20can%20become%20unstable,%2Dsorbitol%20and%20sorbitol%2Dgelatine. Updated 2021. Accessed 2021 Aug 25.
30 Alexander DJ. Newcastle disease and other Paramyxoviruses infection. In: Calnek BW, editor. Disease of Poultry. 10th ed. Ames: Iowa State University Press; 1997, 541-569.
31 Tuan Mohamood NFA. Optimization of carboxymethyl sago starch (CMSS)-acid hydrogel as a potential thermostable carrier for Newcastle disease vaccine [master's thesis]. Serdang: Universiti Putra Malaysia; 2018.
32 Tuan Mohamood NFA, Zainuddin N, Ahmad Ayob M, Tan SW. Preparation, optimization and swelling study of carboxymethyl sago starch (CMSS)-acid hydrogel. Chem Cent J. 2018;12(1):133.   DOI
33 Oyebanji VO, Emikpe BO, Omolade AO, Odeniyi MO, Salami A, Osowole OI, et al. Evaluation of immune response in challenged chickens vaccinated with Newcastle disease vaccine using gums from Cedrela odorata and Khaya senegalensis as delivery agents. J Immunoassay Immunochem. 2017;38(4):378-388.   DOI
34 Kapczynski DR, Afonso CL, Miller PJ. Immune responses of poultry to Newcastle disease virus. Dev Comp Immunol. 2013;41(3):447-453.   DOI
35 Yang HM, Zhao J, Xue J, Yang YL, Zhang GZ. Antigenic variation of LaSota and genotype VII Newcastle disease virus (NDV) and their efficacy against challenge with velogenic NDV. Vaccine. 2017;35(1):27-32.   DOI
36 Mebrahtu K, Teshale S, Esatu W, Habte T, Gelaye E. Evaluation of spray and oral delivery of Newcastle disease I2 vaccine in chicken reared by smallholder farmers in central Ethiopia. BMC Vet Res. 2018;14(1):48.   DOI
37 Kraneveld FC. A poultry disease in the Dutch East Indies. Ned Indische Bl Diergeneeskd. 1926;38:448-450.
38 Miller PJ, Afonso CL, El Attrache J, Dorsey KM, Courtney SC, Guo Z, et al. Effects of Newcastle disease virus vaccine antibodies on the shedding and transmission of challenge viruses. Dev Comp Immunol. 2013;41(4):505-513.   DOI
39 Shohaimi SA, Raus RA, Huai OG, Asmayatim BM, Nayan N, Yusuf AM. Sequence and phylogenetic analysis of Newcastle disease virus genotype VII isolated in Malaysia during 1999-2012. J Teknol. 2015;77(25).
40 Leow BL, Shajarutulwardah MY, Ramlan M. Newcastle disease in Malaysia: diagnostic cases in Veterinary Research Institute (VRI) Ipoh from 2004-2009. Malays J Vet Res (Putrajaya). 2011;2(1):45-51.